Advertisement
Organisation › Details
Fluidigm (Group)
Fluidigm (Nasdaq:FLDM) focuses on the most pressing needs in translational and clinical research, including cancer, immunology, and immunotherapy. Using proprietary CyTOF® and microfluidics technologies, we develop, manufacture, and market multi-omic solutions to drive meaningful insights in health and disease, identify biomarkers to inform decisions, and accelerate the development of more effective therapies. Our customers are leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide. Together with them, we strive to increase the quality of life for all. *
Start | 2001-07-02 existent | |
Today | Fluidigm Corporation (Nasdaq: FLDM) | |
Industry | microfluidics technology | |
Industry 2 | microfluidics product (BCC) | |
Street | 7000 Shoreline Court Suite 100 | |
City | 94080 South San Francisco, CA | |
Tel | +1-650-266-6000 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | n. a. |
Currency | USD | |
Annual sales | 117,243,000 (revenue, total, consolidated (2019) 2019-12-31) | |
Profit | -64,790,000 (2019-12-31) | |
Cash | 49,600,000 (2020-03-31) | |
* Document for »About Section«: Fluidigm Corporation. (4/1/22). "Press Release: Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion". South San Francisco, CA. | ||
Record changed: 2022-04-02 |
Advertisement
More documents for Fluidigm (Group)
- [1] Fluidigm Corporation. (2/10/20). "Press Release: Fluidigm Announces Fourth Quarter and Full Year 2019 Financial Results". South San Francisco, CA....
- [2] MorphoSys AG. (11/20/19). "Press Release: Markus Enzelberger, Chief Scientific Officer of MorphoSys, Announces His Departure". Planegg....
- [3] Fluidigm Corporation. (2/8/18). "Press Release: Fluidigm Announces Fourth Quarter and Full Year 2017 Financial Results and Operational Progress". South San Francisco, CA....
- [4] MorphoSys AG. (10/30/17). "Press Release: Dr. Markus Enzelberger Appointed MorphoSys's Chief Scientific Officer". Planegg....
- [5] Fluidigm Corporation. (10/24/17). "Press Release: Fluidigm Announces Agreement with the University of Zurich to Distribute histoCAT for Multiparameter Imaging Mass Cytometry Data Analysis". South San Francisco, CA....
- [6] Fluidigm Corporation. (10/24/17). "Press Release: Fluidigm Introduces Imaging Mass Cytometry System for Highly Multiplexed Protein Detection in Tissues". South San Francisco, CA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top